Safety, PK, PD, and Antitumor Activity of ARQ 531 in Hematologic Malignancies
about
Safety, PK, PD, and Antitumor Activity of ARQ 531 in Hematologic Malignancies
description
clinical trial
@en
klinisch onderzoek
@nl
name
Safety, PK, PD, and Antitumor Activity of ARQ 531 in Hematologic Malignancies
@en
type
label
Safety, PK, PD, and Antitumor Activity of ARQ 531 in Hematologic Malignancies
@en
prefLabel
Safety, PK, PD, and Antitumor Activity of ARQ 531 in Hematologic Malignancies
@en
P6153
P1050
P1476
A Phase 1 Dose Escalation Stud ...... ctory Hematologic Malignancies
@en
P3098
NCT03162536
P580
2017-07-10T00:00:00Z
P582
2018-12-01T00:00:00Z